Does Epirubicin Hydrochloride Interact with Paclitaxel?
Epirubicin Hydrochloride and Paclitaxel have a moderate drug interaction according to U.S. FDA drug labeling data. Administration of epirubicin immediately prior to or after paclitaxel increases systemic exposure of epirubicin and its metabolites. Monitor for additive hematologic and gastrointestinal toxicity. The mechanism involves increased epirubicin systemic exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Paclitaxel Class
- Microtubule Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Epirubicin Hydrochloride and Paclitaxel occurs because increased epirubicin systemic exposure. Clinically, this means administration of epirubicin immediately prior to or after paclitaxel increases systemic exposure of epirubicin and its metabolites. monitor for additive hematologic and gastrointestinal toxicity. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Epirubicin Hydrochloride and your doctor is considering prescribing Paclitaxel (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider